新闻发布

BioDuro chooses SciFinder to enhance research productivity and shorten cycle times for client success
Collaboration between drug companies and contract research partners drives innovation in evolving business environment.

CAS has expanded its product portfolio with the launch of Formulus®, a new solution aimed at getting innovations to market faster by addressing the unique information needs of formulations scientists.

CAS drives Increase in R&D productivity with launch of breakthrough Retrosynthesis Planner in SciFinder. This
unites advanced technology with CAS’s unmatched collection of chemical reaction data to increase efficiency of chemical synthesis planning.

Aptean and CAS now offer CAS Biosequences content in GenomeQuest. Combining the CAS Biosequences Module and the GQ-Pat database on a single platform delivers a unique, comprehensive “one-stop” search solution for biotechnology intellectual property.

AMRI, a leading global CRO, signs a 5-year Agreement for SciFinder from CAS.

INPI and CAS collaborate to improve patent application examination efficiency with new AI approach. CAS indexing data combined with advanced graph database technologies is proving to be an effective solution to improve patent processing.

The University of Hyogo Chooses SciFinder from CAS To Accelerate Scientific Research and Engineering Education In Japan. Hyogo becomes the first academic institution in Japan leveraging SciFinder to educate its students and empower research.

CAS collaborates with iChemLabs empowering scientists to do better research in less time with SciFinder.
SciFinder provides relevant, highly actionable insights in an easy-to-use interface that integrates the touch screen friendly ChemDoodle chemical structure drawing tool.

CAS, a division of the American Chemical Society (ACS), announced today that Sumitomo Dainippon Pharma has signed a 5-year agreement to provide enterprise-wide access to the newest solution in the SciFinder® family, SciFinder.